Samsung Denies Report That It Wants to Buy Biogen

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit

  • Order Reprints

  • Print Article

Biogen stock jumped on Wednesday after a South Korean newspaper reported that Samsung Group was in talks to acquire the drugmaker.

A Samsung spokesperson told Barron’s in an emailed statement that the report was groundless.

The Korea Economic Daily, citing unnamed investment banking sources, reported that Samsung is engaged in negotiations…